NCT02620254
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
- Locations
-
- Registry participation is worldwide and not limited to this facility Cambridge, Massachusetts, United States
Clinical trial condition
Telangiectasia macularis eruptiva perstans
Explore clinical trials studying Telangiectasia macularis eruptiva perstans. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies